T P

References (3)

Title : Repurposing DPP-4 inhibitors as anticancer agents in KRAS-mutated pancreatic ductal adenocarcinoma - Ramalingam_2025_BMC.Pharmacol.Toxicol_26_208
Author(s) : Ramalingam PS , Hussain MS , Chellasamy G , Elangovan S , Sharma D , T P , Mishra RAK , Kodiveri Muthukaliannan G , Hussain T , Alrokayan S , Balakrishnan P , Mekala JR , Arumugam S
Ref : BMC Pharmacol Toxicol , 26 :208 , 2025
Abstract :
PubMedSearch : Ramalingam_2025_BMC.Pharmacol.Toxicol_26_208
PubMedID: 41361888

Title : Repurposing DPP-4 inhibitors as anticancer agents in KRAS-mutated pancreatic ductal adenocarcinoma - Ramalingam_2025_BMC.Pharmacol.Toxicol_26_208
Author(s) : Ramalingam PS , Hussain MS , Chellasamy G , Elangovan S , Sharma D , T P , Mishra RAK , Kodiveri Muthukaliannan G , Hussain T , Alrokayan S , Balakrishnan P , Mekala JR , Arumugam S
Ref : BMC Pharmacol Toxicol , 26 :208 , 2025
Abstract :
PubMedSearch : Ramalingam_2025_BMC.Pharmacol.Toxicol_26_208
PubMedID: 41361888

Title : Repurposing DPP-4 inhibitors as anticancer agents in KRAS-mutated pancreatic ductal adenocarcinoma - Ramalingam_2025_BMC.Pharmacol.Toxicol_26_208
Author(s) : Ramalingam PS , Hussain MS , Chellasamy G , Elangovan S , Sharma D , T P , Mishra RAK , Kodiveri Muthukaliannan G , Hussain T , Alrokayan S , Balakrishnan P , Mekala JR , Arumugam S
Ref : BMC Pharmacol Toxicol , 26 :208 , 2025
Abstract :
PubMedSearch : Ramalingam_2025_BMC.Pharmacol.Toxicol_26_208
PubMedID: 41361888